Within the United Kingdom (UK) National Health Service, evidence-based screening and surveillance strategies aim to reduce morbidity and mortality secondary to colorectal cancer in asymptomatic and high-risk patients. The primary goal of cancer screening is to identify cancer at an early and more treatable stage when interventions are likely to be more successful. The primary aim of disease surveillance is to reduce colorectal cancer incidence in patients at higher risk of disease by identifying and resecting de novo and missed polyps, thereby preventing their progression to cancer. The secondary aim of disease surveillance is to reduce mortality from bowel cancer. This activity presents evidence-based strategies within the UK National Health Service, epidemiology, aetiology, and pathogenesis, uncovering the roles of genetic, environmental factors, and the adenoma-carcinoma sequence in disease progression. Diverse screening guidelines across UK nations, from faecal occult blood tests to faecal immunochemical tests, and their impact on patient engagement rates are discussed. Insights into detailed surveillance protocols for hereditary colorectal cancer and postsurgical management recommendations by the National Institute for Health and Care Excellence are provided. Contradictions, alternatives to colonoscopy, and the pivotal role of the interprofessional team in advancing screening methods, guideline adherence, and personalized patient care are highlighted.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/161160
- Start Date: 2024-12-01 06:00:00
- End Date: 2024-12-01 06:00:00
- Credit Details: IPCE Credits: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all